Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

NCT01745237 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT01745237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01745237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
Lead sponsor
Duke University
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2002
Completion date
June 30, 2032
Enrollment
27,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoidosis